|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Artibani W, Porcaro AB, De Marco V,
Cerruto MA and Siracusano S: Management of biochemical recurrence
after primary curative treatment for prostate cancer: A review.
Urol Int. 100:251–262. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spahn M, Boxler S, Joniau S, Moschini M,
Tombal B and Karnes RJ: What is the need for prostatic biomarkers
in prostate cancer management? Curr Urol Rep. 16:702015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gaither TL, Merrett SL, Pun MJ and Scott
KC: Centromeric barrier disruption leads to mitotic defects in
schizosaccharomyces pombe. G3 (Bethesda). 4:633–642. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barnhart MC, Kuich PH, Stellfox ME, Ward
JA, Bassett EA, Black BE and Foltz DR: HJURP is a CENP-A chromatin
assembly factor sufficient to form a functional de novo
kinetochore. J Cell Biol. 194:229–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mishra PK, Au WC, Choy JS, Kuich PH, Baker
RE, Foltz DR and Basrai MA: Misregulation of Scm3p/HJURP causes
chromosome instability in saccharomyces cerevisiae and human cells.
PLoS Genet. 7:e10023032011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang W, Mao JH, Zhu W, Jain AK, Liu K,
Brown JB and Karpen GH: Centromere and kinetochore gene
misexpression predicts cancer patient survival and response to
radiotherapy and chemotherapy. Nat Commun. 7:126192016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Verdaasdonk JS and Bloom K: Centromeres:
Unique chromatin structures that drive chromosome segregation. Nat
Rev Mol Cell Biol. 12:320–332. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Foltz DR, Jansen LE, Bailey AO, Yates JR
III, Bassett EA, Wood S, Black BE and Cleveland DW:
Centromere-specific assembly of CENP-a nucleosomes is mediated by
HJURP. Cell. 137:472–484. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Valente V, Serafim RB, de Oliveira LC,
Adorni FS, Torrieri R, Tirapelli DP, Espreafico EM, Oba-Shinjo SM,
Marie SK, Paçó-Larson ML and Carlotti CG Jr: Modulation of HJURP
(Holliday Junction-Recognizing Protein) levels is correlated with
glioblastoma cells survival. PLoS One. 8:e622002013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu Z, Huang G, Sadanandam A, Gu S, Lenburg
ME, Pai M, Bayani N, Blakely EA, Gray JW and Mao JH: The expression
level of HJURP has an independent prognostic impact and predicts
the sensitivity to radiotherapy in breast cancer. Breast Cancer
Res. 12:R182010. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rouam S, Moreau T and Broët P: Identifying
common prognostic factors in genomic cancer studies: A novel index
for censored outcomes. BMC Bioinformatics. 11:1502010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kato T, Sato N, Hayama S, Yamabuki T, Ito
T, Miyamoto M, Kondo S, Nakamura Y and Daigo Y: Activation of
holliday junction recognizing protein involved in the chromosomal
stability and immortality of cancer cells. Cancer Res.
67:8544–8553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Taylor BS, Schultz N, Hieronymus H,
Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva
B, et al: Integrative genomic profiling of human prostate cancer.
Cancer Cell. 18:11–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brimo F, Montironi R, Egevad L,
Erbersdobler A, Lin DW, Nelson JB, Rubin MA, van der Kwast T, Amin
M and Epstein JI: Contemporary grading for prostate cancer:
Implications for patient care. Eur Urol. 63:892–901. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kweldam CF, van Leenders GJ and van der
Kwast T: Grading of prostate cancer: A work in progress.
Histopathology. 74:146–160. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Soares R and Eden CG: Surgical treatment
of high-risk prostate cancer. Minerva Urol Nefrol. 67:33–46.
2015.PubMed/NCBI
|
|
19
|
Giacalone NJ, Wu J, Chen MH, Renshaw A,
Loffredo M, Kantoff PW and D'Amico AV: Prostate-specific antigen
failure and risk of death within comorbidity subgroups among men
with unfavorable-risk prostate cancer treated in a randomized
trial. J Clin Oncol. 34:3781–3786. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao WT, Feng Y, Li ML, Liu GL, Li MZ,
Zeng MS and Song LB: Overexpression of centromere protein H is
significantly associated with breast cancer progression and overall
patient survival. Chin J Cancer. 30:627–637. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McGovern SL, Qi Y, Pusztai L, Symmans WF
and Buchholz TA: Centromere protein-A, an essential centromere
protein, is a prognostic marker for relapse in estrogen
receptor-positive breast cancer. Breast Cancer Res. 14:R722012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dai Y, Liu L, Zeng T, Zhu YH, Li J, Chen
L, Li Y, Yuan YF, Ma S and Guan XY: Characterization of the
oncogenic function of centromere protein F in hepatocellular
carcinoma. Biochem Biophys Res Commun. 436:711–718. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Georgoulis A, Vorgias CE, Chrousos GP and
Rogakou EP: Genome instability and γH2AX. Int J Mol Sci.
18:E19792017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nagaria P, Robert C and Rassool FV: DNA
double-strand break response in stem cells: Mechanisms to maintain
genomic integrity. Biochim Biophys Acta. 1830:2345–2353. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Majidinia M and Yousefi B: DNA damage
response regulation by microRNAs as a therapeutic target in cancer.
DNA Repair (Amst). 47:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Raschellà G, Melino G and Malewicz M: New
factors in mammalian DNA repair-the chromatin connection. Oncogene.
36:4673–4681. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhen Y, Xiao R, Chen X, Yuan C, Sun Y and
Li J: A non-synonymous polymorphism is associated with progression
from chronic hepatitis B virus infection to hepatocellular
carcinoma in a Chinese population. Onco Targets Ther. 11:563–569.
2018. View Article : Google Scholar : PubMed/NCBI
|
